• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome.

作者信息

Sexton Travis R, Wallace Eric L, Macaulay Tracy E, Charnigo Richard J, Evangelista Virgilio, Campbell Charles L, Bailey Alison L, Smyth Susan S

出版信息

J Am Coll Cardiol. 2015 Jan 27;65(3):306-7. doi: 10.1016/j.jacc.2014.10.047.

DOI:10.1016/j.jacc.2014.10.047
PMID:25614429
Abstract
摘要

相似文献

1
The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome.瑞舒伐他汀对急性冠状动脉综合征情况下血小板-白细胞相互作用的影响。
J Am Coll Cardiol. 2015 Jan 27;65(3):306-7. doi: 10.1016/j.jacc.2014.10.047.
2
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).急性冠状动脉综合征中早期大剂量瑞舒伐他汀预防造影剂肾病：来自 PRATO-ACS 研究的结果（瑞舒伐他汀和抗血小板治疗对急性冠状动脉综合征患者造影剂诱导的急性肾损伤和心肌损伤的保护作用）。
J Am Coll Cardiol. 2014;63(1):71-9. doi: 10.1016/j.jacc.2013.04.105. Epub 2013 Sep 26.
3
The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.急性冠状动脉综合征患者经皮冠状动脉介入治疗前高负荷剂量瑞舒伐他汀治疗的效果及机制
Int J Cardiol. 2013 Sep 1;167(5):2350-3. doi: 10.1016/j.ijcard.2012.11.032. Epub 2012 Nov 26.
4
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).炎症与早期大剂量瑞舒伐他汀对急性冠脉综合征患者对比剂肾病获益的关系：PRATO-ACS 研究中的病理生理学联系（瑞舒伐他汀和抗血小板治疗对接受经皮冠状动脉介入治疗的急性冠脉综合征患者对比剂肾病和心肌损伤的保护作用）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1421-9. doi: 10.1016/j.jcin.2014.06.023.
5
Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.瑞舒伐他汀和阿托伐他汀对急性冠状动脉综合征患者载脂蛋白B/载脂蛋白A-1比值的影响：CENTAURUS试验设计。
Arch Cardiovasc Dis. 2008 Jun;101(6):399-406. doi: 10.1016/j.acvd.2008.05.010. Epub 2008 Aug 20.
6
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.早期大剂量瑞舒伐他汀与心脏保护作用——瑞舒伐他汀与抗血小板治疗对急性冠脉综合征患者对比剂诱导的急性肾损伤和心肌损伤的保护作用（PRATO-ACS 研究）
Am Heart J. 2014 Nov;168(5):792-7. doi: 10.1016/j.ahj.2014.08.005. Epub 2014 Aug 10.
7
Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.单次高负荷剂量瑞舒伐他汀对急性冠脉综合征经皮冠状动脉介入治疗的影响。
J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):327-33. doi: 10.1177/1074248412474346. Epub 2013 Jan 29.
8
Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).比较瑞舒伐他汀与阿托伐他汀在急性冠状动脉综合征患者中的调脂疗效（来自 LUNAR 研究）。
Am J Cardiol. 2012 May 1;109(9):1239-46. doi: 10.1016/j.amjcard.2011.12.015. Epub 2012 Feb 21.
9
Therapeutic options for statin-intolerant patients.对他汀类药物不耐受患者的治疗选择。
Curr Med Res Opin. 2012 Mar;28(3):345-9. doi: 10.1185/03007995.2012.657757. Epub 2012 Jan 31.
10
Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES study.依折麦布与他汀类药物联合使用（E-S）对比大剂量瑞舒伐他汀在急性冠脉综合征后的安全性和有效性：SAFE-ES研究
Ann Cardiol Angeiol (Paris). 2014 Sep;63(4):222-7. doi: 10.1016/j.ancard.2014.04.018. Epub 2014 May 2.

引用本文的文献

1
Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.血小板-白细胞聚集体作为心血管疾病中的新型生物标志物
Biology (Basel). 2022 Jan 30;11(2):224. doi: 10.3390/biology11020224.
2
Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects.他汀类药物对血小板活化和功能的影响：从分子途径到临床效果。
Biomed Res Int. 2021 Jan 23;2021:6661847. doi: 10.1155/2021/6661847. eCollection 2021.
3
Effects of Gender-Specific Differences, Inflammatory Response, and Genetic Variation on the Associations Among Depressive Symptoms and the Risk of Major Adverse Coronary Events in Patients With Acute Coronary Syndrome.
性别特异性差异、炎症反应和基因变异对急性冠状动脉综合征患者抑郁症状与主要不良冠状动脉事件风险之间关联的影响。
Biol Res Nurs. 2018 Mar;20(2):168-176. doi: 10.1177/1099800417751662. Epub 2018 Jan 3.
4
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).当代经皮冠状动脉介入治疗后白细胞计数与主要不良心血管事件：PARIS 研究（支架置入患者抗血小板治疗不依从模式注册研究）的见解。
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.117.004981.
5
Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions.他汀类药物在急性冠状动脉综合征中的抗血栓形成作用：血栓形成、炎症与血小板-白细胞相互作用的交叉点
Curr Cardiol Rev. 2016;12(4):324-329. doi: 10.2174/1573403x12666160504100312.